eedq has been researched along with haloperidol in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Cler, JA; Contreras, PC; Dilworth, VM; Iyengar, S; Mick, SJ; Rao, TS; Wood, PL | 1 |
| Civelli, O; Creese, I; Riva, M; van Tol, HH | 1 |
| Cox, RF; Waszczak, BL | 1 |
| Adamovage, LA; Kreamer, LD; Salama, AI; Saller, CF | 1 |
| Bradshaw, WG; Couceyro, P; Okonmah, AD; Soliman, KF | 1 |
| Battaglia, G; Creese, I; Norman, AB | 1 |
| Koyama, T; Kusumi, I; Matsubara, R; Matsubara, S; Yamashita, I | 1 |
| Fuxe, K; Ogren, SO; Rosén, L | 1 |
| Adams, MR; Dobie, DJ; Dorsa, DM; Merchant, KM; Unis, A | 1 |
| Barsoum, SC; Kapur, S; Seeman, P | 1 |
11 other study(ies) available for eedq and haloperidol
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Neurochemical characterization of dopaminergic effects of opipramol, a potent sigma receptor ligand, in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Ligands; Male; Mice; Opipramol; Organ Specificity; Phencyclidine; Piperidines; Quinolines; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Receptors, Opioid; Receptors, Phencyclidine; Receptors, sigma | 1990 |
Lack of effect of chronic dopamine receptor blockade on D2 dopamine receptor mRNA level.
Topics: Adrenergic alpha-Antagonists; Animals; Benzazepines; Blotting, Northern; Clozapine; Corpus Striatum; DNA Probes; Dopamine Antagonists; Haloperidol; Male; Quinolines; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; RNA, Messenger; Salicylamides | 1990 |
Irreversible receptor inactivation reveals differences in dopamine receptor reserve between A9 and A10 dopamine systems: an electrophysiological analysis.
Topics: Animals; Apomorphine; Dopamine; Dopamine Agents; Dopamine Antagonists; Electrophysiology; Evoked Potentials; Haloperidol; Kinetics; Male; Neurons; Quinolines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reference Values; Substantia Nigra; Tegmentum Mesencephali | 1990 |
Dopamine receptor occupancy in vivo: measurement using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Clozapine; Corpus Striatum; Ergolines; Haloperidol; Male; Quinolines; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1989 |
The effect of neuroleptic drugs on serum testosterone level in the male rat.
Topics: Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Haloperidol; Male; Quinolines; Rats; Rats, Inbred Strains; Testosterone; Time Factors | 1986 |
Differential recovery rates of rat D2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: a key to receptor regulatory mechanisms.
Topics: Aging; Animals; Apomorphine; Corpus Striatum; Guanylyl Imidodiphosphate; Haloperidol; In Vitro Techniques; Kinetics; Male; Quinolines; Radioligand Assay; Rats; Rats, Inbred F344; Receptors, Dopamine; Receptors, Dopamine D2; Reserpine; Spiperone | 1987 |
Dopamine D1, D2 and serotonin2 receptor occupation by typical and atypical antipsychotic drugs in vivo.
Topics: Animals; Antipsychotic Agents; Dopamine D2 Receptor Antagonists; Haloperidol; Isoxazoles; Male; Piperidines; Quinolines; Rats; Rats, Wistar; Receptors, Dopamine D1; Risperidone; Serotonin Antagonists | 1993 |
The dopamine D2 antagonist remoxipride acts in vivo on a subpopulation of dopamine D2 receptors.
Topics: Animals; Binding, Competitive; Brain; Catalepsy; Corpus Striatum; Dextroamphetamine; Dose-Response Relationship, Drug; Haloperidol; Limbic System; Male; Motor Activity; Quinolines; Raclopride; Rats; Receptors, Dopamine; Remoxipride; Salicylamides; Substantia Nigra | 1994 |
EEDQ reduces the striatal neurotensin mRNA response to haloperidol.
Topics: Animals; Antipsychotic Agents; Corpus Striatum; Dopamine Antagonists; Gene Expression Regulation; Haloperidol; Male; Neurotensin; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, sigma; RNA, Messenger | 1997 |
Dopamine D(2) receptor blockade by haloperidol. (3)H-raclopride reveals much higher occupancy than EEDQ.
Topics: Animals; Dopamine Antagonists; Haloperidol; Kinetics; Male; Quinolines; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2 | 2000 |